Track the 서울바이오시스 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Technology sector, 서울바이오시스 has recorded 22 insider filings. Market capitalisation: €189.7bn. The latest transaction was disclosed on 10 March 2026 (Other). Among the most active insiders: 서울반도체. All data is openly available.
22
Insider Decl.
n/a
Thresholds
n/a
13 ops.
Buy Volume
n/a
n/a
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,666 of 28,169 companies
48.9
score / 100
Value
64
Quality
34
FCF yld13%
Earn yld-8.1%
EV/EBITDA5.4x
ROE9.2%
Gross mgn14%
Net mgn-2.0%
Debt/EBITDA2.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.